Gender-Related Safety and Outcome in Advanced NSCLC Patients Treated with Immune Checkpoint-Inhibitors. A Real-World Experience

被引：0
|
作者：
Pizzutilo, P. [1 ]
Catino, A. [1 ]
Montrone, M. [1 ]
Longo, V. [1 ]
Ricci, D. [1 ]
Pesola, F. [1 ]
Marech, I. [1 ]
Mastrandrea, A. [1 ]
Petrillo, P. [1 ]
Zacheo, A. [1 ]
Varesano, N. [1 ]
Lamorgese, V. [1 ]
Bafunno, D. [1 ]
Galetta, D. [1 ]
机构：
[1] IRCCS Ist Tumori Giovanni Paolo II, Thorac Oncol, Thorac Oncol Unit, Bari, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Immune checkpoint inhibitors; Gender-related outcome; advanced lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P75.14
引用
收藏
页码：S579 / S580
页数：2
相关论文
共 50 条
  • [31] Immune checkpoint inhibitors plus chemotherapy in patients with locally advanced or metastatic pulmonary sarcomatoid carcinoma: a multicentric real-world study
    Zhou, Fei
    Guo, Haoyue
    Zhou, Xiaolong
    Xie, Huikang
    Tian, Tian
    Zhao, Wencheng
    Gao, Guanghui
    Xiong, Anwen
    Wang, Lei
    Li, Wei
    Chen, Xiaoxia
    Zhang, Yan
    Fan, Jue
    Wu, Fengying
    Zhang, Yongchang
    Zhou, Caicun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [32] Efficacy and safety of immune checkpoint inhibitors in elderly patients with primary liver cancer: a retrospective, multicenter, real-world cohort study
    Lushan Xiao
    Yanxia Liao
    Jiaren Wang
    Qimei Li
    Hongbo Zhu
    Chang Hong
    Ruining Li
    Jingzhe He
    Hao Cui
    Hanzhi Dong
    Lin Zeng
    Li Liu
    Cancer Immunology, Immunotherapy, 2023, 72 : 2299 - 2308
  • [33] Real-world effectiveness of immune checkpoint inhibitors and BRAF/ MEK inhibitors among veteran patients with cutaneous melanoma
    Kim, Daniel Y.
    Swetter, Susan M.
    Huhmann, Linden
    Dizon, Matthew P.
    Ferguson, Jacqueline M.
    Osborne, Thomas F.
    Spence, Allyson C.
    Ziad, Amina
    Fillmore, Nathanael
    Hartman, Rebecca I.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (03) : 620 - 623
  • [34] Efficacy and safety of immune checkpoint inhibitors in elderly patients with primary liver cancer: a retrospective, multicenter, real-world cohort study
    Xiao, Lushan
    Liao, Yanxia
    Wang, Jiaren
    Li, Qimei
    Zhu, Hongbo
    Hong, Chang
    Li, Ruining
    He, Jingzhe
    Cui, Hao
    Dong, Hanzhi
    Zeng, Lin
    Liu, Li
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (07) : 2299 - 2308
  • [35] Immune-Related Pneumonitis in NSCLC Patients Treated with Immune Checkpoint Inhibitors (ICI): Impact of Previous Thoracic Radiotherapy
    Botticella, A.
    Ibrahim, T.
    Mezquita, L.
    Hendriks, L.
    Le Pavec, J.
    Ferrara, R.
    Caramella, C.
    Remon, J.
    Champiat, S.
    Michot, J.
    Lavaud, P.
    Nana, F. Aboubakar
    Gustin, P.
    Planchard, D.
    Gazzah, A.
    Marabelle, A.
    Eric, D.
    Besse, B.
    Le Pechoux, C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S461 - S462
  • [36] Immune checkpoint inhibitors-associated risk of immune-related hypothyroidism in older patients with advanced melanoma: a real-world analysis of US SEER-Medicare data
    Almutairi, Abdulaali R.
    Erstad, Brian L.
    McBride, Ali
    Slack, Marion
    Abraham, Ivo
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (04) : 489 - 497
  • [37] Efficacy and Safety Analysis of Immune Checkpoint Inhibitors plus Angiogenesis Inhibitors for the Treatment of Advanced Driver-negative NSCLC in Patients: A
    Zhang, Jian
    Zou, Zhonghua
    Tan, Jie
    Shi, Jianping
    Yang, Hui
    Wang, Hao
    Zhou, Jundong
    Xue, Jing
    JOURNAL OF CANCER, 2023, 14 (09): : 1623 - 1634
  • [38] Real-World Clinical and Economic Outcomes in Selected Immune-Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors
    Zheng, Ying
    Kim, Ruth
    Yu, Ting
    Gayle, Julie A.
    Wassel, Christina L.
    Dreyfus, Jill
    Phatak, Hemant
    George, Saby
    ONCOLOGIST, 2021, 26 (11) : E2002 - E2012
  • [39] Real-World Comparison of Health-Related Quality of Life Associated with Use of Immune-Checkpoint Inhibitors in Oncology Patients
    Alwhaibi, Abdulrahman
    Alenazi, Miteb A.
    Alnofaie, Saad D.
    Aldekhail, Abdullah M.
    Alanazi, Rakan J.
    Alghadeer, Sultan
    Alghamdi, Abdulrhman A.
    Alanazi, Saleh A.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (16)
  • [40] The Early Landscape of Immune Cell Subsets in Metastatic NSCLC Patients Treated with Immune Checkpoint Inhibitors
    Zhou, J.
    Donaubauer, A.
    Frey, B.
    Becker, I.
    Rutzner, S.
    Sun, R.
    Ma, H.
    Fietkau, R.
    Deutsch, E.
    Gaipl, U.
    Hecht, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S336 - S336
12345